KALVISTA PHARMACEUTICALS INC (KALV) Institutional Ownership and Insiders Activity

KALVISTA PHARMACEUTICALS INC (KALV) is widely held by institutional investors, with 6 firms reporting positions valued at approximately $990,473 based on SEC Form 13F filings for the quarter ended March 31, 2026.

Ubs Am, A Distinct Business Unit Of Ubs Asset Management Americas Llc is the largest disclosed holder, reporting approximately $699,377 in KALV holdings in its latest filing.

Institutional ownership remains highly concentrated, with Ubs Am, A Distinct Business Unit Of Ubs Asset Management Americas Llc representing the majority of disclosed value.